DK2978840T3 - Human blod-hjernebarrieremodel afledt af stamceller - Google Patents

Human blod-hjernebarrieremodel afledt af stamceller Download PDF

Info

Publication number
DK2978840T3
DK2978840T3 DK14722738.3T DK14722738T DK2978840T3 DK 2978840 T3 DK2978840 T3 DK 2978840T3 DK 14722738 T DK14722738 T DK 14722738T DK 2978840 T3 DK2978840 T3 DK 2978840T3
Authority
DK
Denmark
Prior art keywords
stem cells
brain barrier
human blood
model derived
barrier model
Prior art date
Application number
DK14722738.3T
Other languages
English (en)
Inventor
Roméo Paul Cecchelli
Sezin Aday
Silva Ferreira Lino Da
Emmanuel Bernard Sevin
Original Assignee
Biocant Centro De Inovacao Em Biotecnologia
Univ Of Artois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocant Centro De Inovacao Em Biotecnologia, Univ Of Artois filed Critical Biocant Centro De Inovacao Em Biotecnologia
Application granted granted Critical
Publication of DK2978840T3 publication Critical patent/DK2978840T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
    • C12N2502/086—Coculture with; Conditioned medium produced by cells of the nervous system glial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK14722738.3T 2013-03-26 2014-03-26 Human blod-hjernebarrieremodel afledt af stamceller DK2978840T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT10685513 2013-03-26
PCT/IB2014/060186 WO2014203087A1 (en) 2013-03-26 2014-03-26 A human blood-brain barrier model derived from stem cells

Publications (1)

Publication Number Publication Date
DK2978840T3 true DK2978840T3 (da) 2020-11-30

Family

ID=50685978

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14722738.3T DK2978840T3 (da) 2013-03-26 2014-03-26 Human blod-hjernebarrieremodel afledt af stamceller

Country Status (6)

Country Link
US (2) US20160040125A1 (da)
EP (1) EP2978840B1 (da)
DK (1) DK2978840T3 (da)
ES (1) ES2841124T3 (da)
PT (1) PT2978840T (da)
WO (1) WO2014203087A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11820975B2 (en) * 2014-12-09 2023-11-21 National Research Council Of Canada Human blood brain barrier model
EP3551051A4 (en) * 2016-12-09 2021-01-06 Loma Linda University Health METHODS FOR DIAGNOSING ALZHEIMER'S DISEASE AND THE RISK OF DEVELOPING ALZHEIMER'S DISEASE
US10457717B2 (en) 2017-02-17 2019-10-29 Denali Therapeutics Inc. Engineered polypeptides
SI3583120T1 (sl) 2017-02-17 2023-02-28 Denali Therapeutics Inc. Inženirani polipeptidi, ki vezujejo transferinske receptorje
US10143187B2 (en) 2017-02-17 2018-12-04 Denali Therapeutics Inc. Transferrin receptor transgenic models
CN110438063B (zh) * 2018-05-04 2023-04-14 中国人民解放军海军军医大学 人源化类脑器官缺血模型制备及应用
CN108853589A (zh) * 2018-06-11 2018-11-23 上海风劲生物医药科技有限公司 人源化类脑器官在脑损伤运动障碍疾病中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1817410B1 (en) 2004-11-29 2015-01-07 Institut National De La Sante Et De La Recherche Medicale (Inserm) Human blood brain barrier model
JP5113332B2 (ja) 2005-12-19 2013-01-09 正美 丹羽 血液脳関門インヴィトロ・モデル、病態血液脳関門インヴィトロ・モデル、及びこれを用いた薬物スクリーニング方法、病態血液脳関門機能解析方法、病因解析方法
US20100233132A1 (en) 2006-05-25 2010-09-16 Massachusetts Institute Of Technology Formation of vascular networks using embryonic stem cells
US9902940B2 (en) 2010-06-17 2018-02-27 Wisconsin Alumni Research Foundation Human blood-brain barrier endothelial cells derived from pluripotent stem cells and blood-brain barrier model thereof

Also Published As

Publication number Publication date
EP2978840B1 (en) 2020-09-30
US20160040125A1 (en) 2016-02-11
PT2978840T (pt) 2021-01-06
EP2978840A1 (en) 2016-02-03
WO2014203087A1 (en) 2014-12-24
US20210380938A1 (en) 2021-12-09
ES2841124T3 (es) 2021-07-07

Similar Documents

Publication Publication Date Title
BR112015006198A2 (pt) conjunto de cadeira
DK2923081T3 (da) Vertikalakseturbine
DE112014000689A5 (de) Al-Gusslegierung
DK2668967T3 (da) Implantat
BR112014027026A2 (pt) aerofólio
DK3234476T3 (da) Solfanger
DK2978840T3 (da) Human blod-hjernebarrieremodel afledt af stamceller
DK3071675T3 (da) Kombineret energinet
DK2961830T3 (da) Hudmodel
DK3083944T3 (da) Pattedyrsmuskelafledte stamceller
DK2882938T3 (da) Turbinearrangement
DK2967936T3 (da) Skrå stent
BR302012005880S1 (pt) Configuração aplicada em prótese
FR2995524B1 (fr) Prothese endo-urinaire
FR3012417B1 (fr) Nacelle de turboreacteur
FR3009951B1 (fr) Prothese intra-laryngee
ES1078038Y (es) Aposito ocular
DE112013005702A5 (de) Pfosten
FI20135236A (fi) Haudutin
ITCH20130009U1 (it) Turbina eolica modulabile
TH1501002598B (th) เสา
UA24906S (uk) Напіввагон моделі 12-9933
CO6980135A1 (es) Implante hibrido natural
LU91970B1 (fr) Turbine
FI10431U1 (fi) Anturamuottielementti